HCW Biologics Inc. (HCWB)
HCW Biologics Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
HCW Biologics Inc. (HCWB) is a Biotechnology company based in US with a market capitalization of $4.3M. Revenue declined 97.9% year-over-year and free cash flow was negative at -$13.4M. This page tracks HCWB's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 36 employees · IPO Jul 20, 2021
Valuation
Valuation & price
$1.22as of May 17, 2026· -96.6% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
1.55
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$4.3M
Market cap
-97.9%
Revenue growth (YoY)
20.0%
Gross margin
-$13.4M
Free cash flow (USD)
$4.9M
Net debt
-94.6%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2019 → 2025
Free cash flow by year
2019 → 2025
Gross margin by year
2022 → 2025
Value screen
Graham defensive-investor tests
3
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 14, 2026 (EPS $0.37)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJul 1, 2026Filing
Settlement Agreement Completed
- 8-K eventJun 30, 2026Filing
Regained Compliance
- 8-K eventJun 26, 2026Filing
Reverse Stock Split
- 8-K eventJun 16, 2026Filing
Clinical Trial Results
- 8-K eventJun 15, 2026Filing
Annual Meeting Results
- 8-K eventJun 1, 2026Filing
Delisting Notice
- Insider buyMay 27, 2026Filing
Insider Buy $20KByam Rebecca · Chief Financial Officer · $20K
- Insider buyMay 27, 2026Filing
Insider Buy $250KGARRETT SCOTT T · Director · $250K
- Insider buyMay 27, 2026Filing
Insider Buy $160KWong Hing C · Director, Chief Executive Officer, 10% Owner · $160K
- 8-K eventMay 27, 2026Filing
License Agreement Termination
Questions
Frequently asked questions
What is HCW Biologics Inc.'s market cap?
HCW Biologics Inc. (HCWB) has a market capitalization of $4.3M.
What is HCWB's P/E ratio?
A meaningful P/E ratio is not available for HCWB — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is HCWB's price-to-book (P/B) ratio?
HCWB trades at 1.55 times book value per share.
When did HCW Biologics Inc. last report earnings?
HCWB last reported earnings on May 14, 2026; the next date is not yet scheduled.
Are insiders buying HCWB stock?
Yes — SEC Form 4 filings show 3 open-market insider buys and 0 sells at HCW Biologics Inc. in the last 90 days.
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.